Prediction of clinically significant prostate cancer using polygenic risk models in Asians.
Sang Hun SongEunae KimEunjin WooEunkyung KwonSungroh YoonJung Kwon KimHakmin LeeJong Jin OhSangchul LeeSung Kyu HongSeok-Soo ByunPublished in: Investigative and clinical urology (2022)
Ethnic-specific PRS was developed and validated in Korean males to predict csPCa susceptibility using the largest csPCa sample size in Asia. PRS can be a potential biomarker to predict individual risk. Future multi-ethnic trials are required to further validate our results.
Keyphrases